Mastication tablet for women's climacteric-syndrome-relieving as well as processing method

Abstract

The invention relates to a health product used in a climacteric-syndrome-relieving tablet of women, in particular to a chewable tablet of the climacteric-syndrome-relieving tablet of women. The invention is characterized in that: the invention comprises the raw materials in weight percentage content that: 0.5 to 1.5 percent of plant isoflavone, 15 to 20 percent of medlar, 50 to 60 percent of black bean, 10 to 15 percent of mushroom, 2 to 2.5 percent of red yeast rice and 1 to 2 percent of active ferment; the processing method comprises the steps that: the black bean and sundries in the materials are eliminated and swelled with microwave, the fishy smell eliminated and the raw material is crushed to 80 to 100 items; the medlar and mushrom in the materials are dried by microwave and crushed to 80 to 100 items; the red yeast rice are crushed to 80 to 100 items; percent plant isoflavone, active ferment and crushed black bean, meldar, mushroom and red yeast rich are richly mixed and stirred to the semi-manufactured products according to the weight content, the semi-manufacutured products are extruded to the chawing pieces by extrusion moulding machine, the medlar leaves are crushed after being dried by microwave; the products are packed by packing machine and used for dunking tea; the chawing pieces are produced to small packages and meldar leaves bags for dunking tea; storage is the last process. The invention can delay the menopause of women, and can reduce the symptom in menopause. Having no poisonous and side effects, the invention is reliable and safe.

Description

technical field [0001] The invention relates to a health product for women's mengnian'an, in particular to a woman's mengnian'an chewable tablet and a processing method thereof. Background technique [0002] Menopause is a process that every woman has to go through. Some women have depression, hot flashes and night sweats, lack of sleep, bad temper, vaginal dryness and atrophy, and frigidity. The hair is also becoming less and less supple and without nutrition. The drug estrogen discovered in 1942 has made outstanding contributions to women's delay of aging and the reduction of menopausal symptoms. However, in 2002, the Heart, Lung and Blood Institute of the United States and other countries found that postmenopausal women who took drug estrogen for more than 5 years greatly increased Risk of breast cancer, heart and brain diseases, stroke and cerebral thrombosis. Therefore so far, there is no health care product that can delay the symptoms of women's menopause without tox...

AI Technical Summary

Problems solved by technology

The drug estrogen discovered in 1942 has made outstanding contributions to women's delay of aging and the reduction of menopausal symptoms. However, in 2002, the Heart, Lung and Blood Institute of the United States and other countries found that postmenopausal women who took drug estrogen for more than 5 years greatly increased Chances of breast cancer, heart and brain diseases, stroke and cerebral thrombosis

Therefore, so far, there is no health product that can delay the symptoms of women's menopause, has no toxic side effects, and can also slow down the symptoms of women's menopause such as tooth atrophy and looseness, cold hands and feet, hair loss, and weak waist and legs.